Graham Hastie1, Mazen Soufi1, James Wilson1, Bibhas Roy1. 1. Central Manchester University Hospitals NHS Trust, Trafford General Hospital, Moorside Road, Manchester M41 5SL, United Kingdom.
Abstract
OBJECTIVE: We aimed to assess the effectiveness of PRP injections in lateral epicondylitis of the elbow as it was felt after PRP introduction the numbers of patients requiring surgery for had reduced. METHODS: We conducted a retrospective review of cases from the 1st January 2008 to 31st December 2015. The numbers of patients undergoing surgical release and the numbers of patients requiring PRP injections were recorded each year and the numbers of patients requiring surgery was compared pre and post PRP injection to ascertain if PRP introduction reduced surgical intervention. RESULTS: Prior to PRP, a yearly mean of 12.75 patients underwent surgery, since PRP this reduced to 4.25 patients, P < 0.001. This leads to an absolute risk reduction of 0.773 and number needed to treat of 1.3. PRP injection successfully reduced symptoms in 56/64 (87.5%) patients in our study. CONCLUSION: We consider PRP injection, for intractable lateral epicondylitis of the elbow, not only a safe but also very effective tool in reducing symptoms and have shown it has reduced the need for surgical intervention in this difficult cohort of patients.
OBJECTIVE: We aimed to assess the effectiveness of PRP injections in lateral epicondylitis of the elbow as it was felt after PRP introduction the numbers of patients requiring surgery for had reduced. METHODS: We conducted a retrospective review of cases from the 1st January 2008 to 31st December 2015. The numbers of patients undergoing surgical release and the numbers of patients requiring PRP injections were recorded each year and the numbers of patients requiring surgery was compared pre and post PRP injection to ascertain if PRP introduction reduced surgical intervention. RESULTS: Prior to PRP, a yearly mean of 12.75 patients underwent surgery, since PRP this reduced to 4.25 patients, P < 0.001. This leads to an absolute risk reduction of 0.773 and number needed to treat of 1.3. PRP injection successfully reduced symptoms in 56/64 (87.5%) patients in our study. CONCLUSION: We consider PRP injection, for intractable lateral epicondylitis of the elbow, not only a safe but also very effective tool in reducing symptoms and have shown it has reduced the need for surgical intervention in this difficult cohort of patients.
Authors: Gregory N Nelson; Tiffany Wu; Leesa M Galatz; Ken Yamaguchi; Jay D Keener Journal: J Shoulder Elbow Surg Date: 2013-12-14 Impact factor: 3.019
Authors: Allan K Mishra; Nebojsa V Skrepnik; Scott G Edwards; Grant L Jones; Steven Sampson; Doug A Vermillion; Matthew L Ramsey; David C Karli; Arthur C Rettig Journal: Am J Sports Med Date: 2013-07-03 Impact factor: 6.202
Authors: Thomas L Sanders; Hilal Maradit Kremers; Andrew J Bryan; Jeanine E Ransom; Jay Smith; Bernard F Morrey Journal: Am J Sports Med Date: 2015-02-05 Impact factor: 6.202
Authors: Marieke de Mos; Anna E van der Windt; Holger Jahr; Hans T M van Schie; Harrie Weinans; Jan A N Verhaar; Gerjo J V M van Osch Journal: Am J Sports Med Date: 2008-03-07 Impact factor: 6.202
Authors: Seyed Ahmad Raeissadat; Leyla Sedighipour; Seyed Mansoor Rayegani; Mohammad Hasan Bahrami; Masume Bayat; Rosa Rahimi Journal: Pain Res Treat Date: 2014-01-20